The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Hidradenitis Suppurativa Tied to Higher Mortality

Hidradenitis Suppurativa Tied to Higher Mortality

February 24, 2016 • By David Douglas

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Hidradenitis suppurativa (HS) is associated with a significantly increased risk of adverse cardiovascular (CV) outcomes and all-cause mortality, according to Danish researchers.

You Might Also Like
  • Hidradenitis Suppurativa Can Complicate Biologic Therapy
  • IBD Tied to Higher Risk of Invasive Pneumococcal Disease
  • Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA

HS is a chronic, inflammatory skin disease and is most common in women. It is typically diagnosed after long delays, Dr. Alexander Egeberg of the University of Copenhagen and colleagues note in JAMA Dermatology, online on Feb. 12.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Previous studies from other inflammatory disorders, such as psoriasis, have suggested that their cardiovascular risk factors appear to be markedly undertreated in clinical practice,” Dr. Egeberg told Reuters Health by email. “Our findings therefore warrant increased focus on cardiovascular risk and modifiable risk factors in patients with HS.”

To investigate its possible consequences, the researchers studied data on almost 6,000 patients (73% women) with a hospital-based HS diagnosis, and more than 29,000 matched controls.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Over a mean follow-up of 7.1 years there were 62 myocardial infarctions in the HS group and 138 in controls giving an adjusted independent risk ratio of 1.57 (p=0.005).

There were 74 ischemic strokes in the HS group and 208 in controls (IRR, 1.33; p=0.04). CV-associated death was also more likely among HS patients (IRR, 1.95; p<0.001) as were major adverse CV events (IRR, 1.53; p=0.001) and all-cause mortality (IRR, 1.35; p=0.005).

The researchers then went on to compare the HS patients with more than 13,000 patients with severe psoriasis. After adjustment, both groups had similarly elevated risks of outcomes including stroke and MI, but the HS group had a significantly increased risk of CV-associated death (IRR 1.58).

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Among limitations of the study, the researchers note, is “that patients with HS seen in hospital settings have more comorbidities than do those sampled from a population setting.”

However, given that HS was “associated with a significantly increased risk of adverse CV outcomes and all-cause mortality independent of measured confounders,” they call for “increased awareness of this association and for studies of its clinical consequences.”

Commenting on the findings by email, Dr. F.W. Danby of Manchester, N.H., who is president of the Hidradenitis Suppurativa Foundation, told Reuters Health that, “Patients with HS are known to run low levels of vitamin D3.” In turn, “Low levels of vitamin D3 are associated with increased cardiac risk.”

Additional study may be required, but, said Dr. Danby, “Vitamin D3 supplementation is now recommended for patients with HS.”

Filed Under: Conditions, Scleroderma Tagged With: cardiovascular, Cardiovascular disease, Hidradenitis suppurativa, Psoriasis, skin, skin inflammation

You Might Also Like:
  • Hidradenitis Suppurativa Can Complicate Biologic Therapy
  • IBD Tied to Higher Risk of Invasive Pneumococcal Disease
  • Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA
  • Psoriasis Tied to Higher Risk of Serious Liver Disease

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)